Physician profile
John Lukeman
NPI 1922424662
$2,231.62
in general payments reported to CMS, 2019-2025
34 companies · $413 in 2025
The $413 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $196 · 2021: $112 · 2022: $212 · 2023: $412 · 2024: $505 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $376.09 | 2023-2025 | Azstarys |
| Lilly USA, LLC | $180.58 | 2023-2024 | Jardiance, Mounjaro, Trulicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $169.70 | 2019-2025 | Xifaxan |
| Novo Nordisk INC | $169.55 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $161.91 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $156.91 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Amarin Pharma, INC. | $110.10 | 2019-2021 | |
| Genentech USA, INC. | $108.45 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.11 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $44.87 | 2019-2020 | |
| Medtronic, INC. | $44.06 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $42.41 | 2021-2022 | |
| Dexcom, INC. | $40.23 | 2023-2024 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $38.88 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $38.68 | 2024 | Veozah |
| Seqirus USA INC | $38.34 | 2023-2025 | Flucelvax, Fluad, Fluad Quadrivalent |
| Sanofi Pasteur INC. | $36.75 | 2022 | |
| Dynavax Technologies Corporation | $35.25 | 2024 | Heplisav-B |
| Abbvie INC. | $34.87 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.18 | 2022 | |
| Glaxosmithkline, LLC. | $30.24 | 2020-2025 | Trelegy Ellipta |
| Antares Pharma, INC. | $26.75 | 2019 | |
| Amgen INC. | $26.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $26.21 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.90 | 2019 | |
| Boston Scientific Corporation | $21.68 | 2019 | |
| Supernus Pharmaceuticals, INC. | $20.11 | 2022 | |
| Exact Sciences Corporation | $19.19 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $16.00 | 2024 | Quviviq |
| Abbott Laboratories | $15.24 | 2023 | Freestyle Libre 3 |
| Insulet Corporation | $14.61 | 2020 | |
| Shire North American Group INC | $10.80 | 2019 | |
| Phathom Pharmaceuticals, INC. | $8.10 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lukeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.